FDAnews
www.fdanews.com/articles/138821-fda-warns-indian-generics-maker-for-multiple-gmp-violations

FDA Warns Indian Generics Maker for Multiple GMP Violations

August 1, 2011
The FDA has warned Indian active pharmaceutical ingredient (API) and generics maker Zydus Group, a division of Cadila Healthcare, for a number of current good manufacturing practice (cGMP) violations, including incomplete test data.
Generic Line